- 2
- 1
- 1
Francois Chevalier
François Chevalier
4
Documents
Affiliations actuelles
- 1061150
- 53953
- 56527
- 20287
Identifiants chercheurs
- francois-chevalier
- 0000-0002-8488-2324
- IdRef : 060862440
Présentation
Dr. François Chevalier, PhD, HDR, with a background in protein chemistry and molecular biology, received his doctoral degree in biochemistry in 2001 (INRA, Nantes, France), for the biochemical characterization of glycated proteins. He did a 5 years post-doctoral research positions in Montpellier (INRA, France) with a special focus on global analysis of proteins using two-dimensional electrophoresis and mass spectrometry. Following a research positions in Cork (UCC, Ireland) with a study of protein quality using proteomics tools, he is currently employed in CEA (DRF-IRAMIS-CIMAP in Caen) as team leader in radiation biology in the ARIA group (Applications in Radiobiology with Accelerated Ions).
Dr. François Chevalier is specialized in radiation-biology of radioresistant cancer models and bystander effects in a context of hadrontherapy.
He has published more than 70 scientific and technical papers in peer reviewed journals.
Domaines de recherche
Cancer
Biologie cellulaire
Génomique, Transcriptomique et Protéomique [q-bio.GN]
Biochimie, Biologie Moléculaire
Publications
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 1
|
A Proteomic Study Suggests Stress Granules as New Potential Actors in Radiation-Induced Bystander EffectsInternational Journal of Molecular Sciences, 2021, 22 (15), pp.7957. ⟨10.3390/ijms22157957⟩
Article dans une revue
hal-03301338v1
|
|
Proteomic analysis of bystander effects in chondrosarcoma cellsPoster de conférence hal-03144446v1 |
|
P47. Proteomic analysis of the Radiation-Induced Bystander Effects between low-dose irradiated Chondrosarcoma cells and Bystander Chondrocytes4th European Radiation Protection Week, Oct 2019, Stockholm, Sweden
Poster de conférence
hal-03144468v1
|
|
Discriminating sub-population responses of a mixture of human cell lines by proteogenomics43rd FEBS Congress, Biochemistry Forever, Prague, Czech Republic, July 7-12, 2018, Jul 2018, Prague (CZ), France
Poster de conférence
hal-04475761v1
|